Reply: Comment on The Necessity of Guidance: Optimizing Adjuvant Therapy for Stage II/III MSI-H Gastric Cancer Through the Interplay of Evidence, Clinical Judgment, and Patient Preferences
-
- Journal of Gastric Cancer
- /
- v.24 no.4
- /
- pp.353-355
- /
- 2024